The Effectiveness Of Atezolizumab Under Real-World Conditions In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy
The Effectiveness Of Atezolizumab Under Real-World Conditions In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy
Hyperion Is A Prospective, Multicenter, Non-Interventional, Two-Cohort Study Collecting Primary Data In Patients With Locally Advanced Or Metastatic NSCLC Of Squamous Or Non-Squamous Histology After Prior Chemotherapy Being Treated With Atezolizumab In Routine Clinical Practice.
Inclusion Criteria:
Retrospective Inclusion:
Exclusion Criteria:
Patients not eligible for Atezolizumab treatment according to SmPC
Baden-Baden, 76530, Germany
Berlin, 10407, Germany
Bielefeld, 33604, Germany
Bielefeld, 33604, Germany
Coswig, 01640, Germany
Dresden, 01307, Germany
Eberswalde, 16225, Germany
Frankenthal/Pfalz, 67227, Germany
Frankfurt, 60590, Germany
Frankfurt am Main, 65929, Germany
Garbsen, 30827, Germany
Hof, 95028, Germany
Leipzig, 04103, Germany
Magdeburg, 39130, Germany
Marburg, 35043, Germany
Mutlangen, 73557, Germany
Neumünster, 24534, Germany
Offenburg, 77654, Germany
Porta Westfalica, 32457, Germany
Stade, 21680, Germany
Tübingen, 72076, Germany
Ulm, 89081, Germany
Westerstede, 26655, Germany
Wuppertal, 42283, Germany